Skip to content

Difference Strain Ratio Ultrasound Elastography Between Benign and Malignant Peripheral Lung Lesions

Difference In Strain Ratio Ultrasound Elastography Between Benign And Malignant Peripheral Parenchymal Lung Lesions.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05752227
Enrollment
120
Registered
2023-03-02
Start date
2022-06-01
Completion date
2023-03-31
Last updated
2023-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Lung Lesions

Brief summary

Diagnostic accuracy study to investigate the sensitivity and specificity of sonographic elastography using strain ratio to differentiate between benign and malignant peripheral lesions in comparison to biopsy, clinically, or radiologically.

Detailed description

This is a diagnostic accuracy study with comparison to gold standard tests e.g., chest computed tomography, transthoracic biopsy, or microbiological analysis. All patients included in this study will give informed consent according to the guidelines of ethics committee, Alexandria Faculty of Medicine. (http://www.med.alexu.edu.eg/wp-content/uploads/2012/04/Checklist-FINAL- 20141.pdf-)

Interventions

PROCEDURETransthoracic biopsy

Us guided transthoracic biopsy

RADIATIONCT chest

Computed tomography

Sponsors

Alexandria University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 1\) Adult patients above age of 18 years old. 2) Patients with peripheral lung lesion.

Exclusion criteria

1. Pure pleural lesions. 2. Clinical instability to reach the final diagnosis. 3. Inaccessibility by ultrasound.

Design outcomes

Primary

MeasureTime frameDescription
Cut off value strain ratio6-9 monthsTo differentiate between benign and malignant lung lesions using strain ratio

Countries

Egypt

Contacts

Primary ContactAhmed F Abouelnour
abouelnourahmed@gmail.com01111609023

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026